Skip to main content
. 2022 Oct 18;2022:5048061. doi: 10.1155/2022/5048061

Table 2.

Assessment of outcomes.

Outcomes Pancreatitis with jaundice Pancreatitis without jaundice p-Value
In-hospital mortality
∗Missing—920 4.3% 2.1% <0.0001
1.51 (1.35–1.68) <0.0001
Length of stay, days (mean, IQR) 4 (3–8) 4 (2–6) 0.0023
Total hospitalization cost, $ (median, IQR) 11,412 (6843–19,216) 7893 (4840–13,842) <0.0001
In-hospital complications
 ARDS 0.4% 0.3% 0.08
 Ventilator dependence respiratory failure 0.23% 0.29% 0.25
 Dehydration and electrolyte disorders 47.6% 43.8% <0.0001
 Septicemia 15.2% 9.6% <0.0001
 Septic shock 4.1% 2.9% <0.0001
 Prolonged ileus 0.3% 0.2% 0.38
 Ascites 6.5% 3.1% <0.0001
 Hypoalbuminemia 2.5% 1.4% <0.0001
 AKI 17.8% 14.9% <0.0001
 Peritonitis 1.8% 1.4% 0.0008
 Perforation of intestine 0.06% 0.2% 0.006
 Toxic megacolon 0.11% 0.17% 0.17
 Acute liver failure 1.6% 1.1% <0.0001
Disposition <0.0001
 Discharge to home 68.9% 74.9%
 Transfer other: Includes skilled 10.1% 8.6%
 Nursing facility (SNF), intermediate
 Care facility (ICF) and another type of facility
 Home health care 8.5% 8.1%
 Against medical advice (AMA) 1.6% 3.4%
∗Missing—920

Adjusted for age, race, gender, Elixhauser comorbidities, primary payer, and hospital teaching status.